Prot #M13-740: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are

Project: Research project

Project Details

StatusFinished
Effective start/end date12/9/1512/9/18

Funding

  • Covance Inc. (Prot #M13-740)
  • AbbVie Inc. (Prot #M13-740)